Gallman Cari bought BMY
March 10, 2024 · Form 4 insider transaction
Gallman Cari bought 2,094 shares of Bristol-Myers Squibb Company at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,094
Price
$0.00
Total value
N/A
InsiderGallman Cari
Role—
SecurityCommon Stock, $0.10 par value
Transaction codeM: Option exercise
Transaction dateMarch 10, 2024
Filing dateMarch 12, 2024
Shares owned after2,655
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Amount represents distribution of performance shares earned under the 2021-2023 Long-Term Performance Award.